Chemistry:Carotuximab

From HandWiki
Short description: Monoclonal antibody
Carotuximab
Monoclonal antibody
Type?
SourceChimeric (mouse/human)
Targetendoglin
Clinical data
Other namesTRC-105
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6420H9922N1718O2010S46
Molar mass144808.77 g·mol−1

Carotuximab (INN[1]) (TRC-105) is a chimeric monoclonal antibody designed for the treatment of cancer.

This drug was developed by Tracon Pharmaceuticals Inc.[2]

It is at Phase III trials for angiosarcoma.

References